Article
[Genomic, proteomic and metabolomic predictors of nonalcoholic fatty liver disease development in obese patients. Part I].
Voprosy pitaniia - 1 Jan 2015
Chernyak O O, Sentsova T B, Vorozhko I V, Tutelyan V A, Gapparova K M, Isakov V A
Abstract excerpt
The prevention, diagnosis and treatment of diseases associated to obesity require a qualitative increase of efficiency. There are still disputable questions about diagnostic significance of some molecules, including genomic, proteomic and metabolomic biomarkers. We observed 72 obese patients (20 men and 52 women, mean age--41.3 +/- 2.5) and performed ultrasound elastography and ultrasound of liver. We have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
